跳转至内容
Merck
CN

T2255

三氟胸苷

≥99% (HPLC), synthetic, powder

别名:

α,α,α-三氟胸苷, 2′-脱氧-5-三氟甲基尿苷, 三氟胸腺嘧啶脱氧核苷, 曲氟尿苷

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C10H11F3N2O5
化学文摘社编号:
分子量:
296.20
NACRES:
NA.51
PubChem Substance ID:
UNSPSC Code:
41106305
EC Number:
200-722-8
MDL number:
Assay:
≥99% (HPLC)
Biological source:
synthetic
Form:
powder
Solubility:
water: 50 mg/mL, clear, colorless
Storage temp.:
−20°C
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

三氟胸苷, ≥99% (HPLC)

biological source

synthetic

Quality Level

assay

≥99% (HPLC)

form

powder

mp

190-193 °C (lit.)

solubility

water: 50 mg/mL, clear, colorless

storage temp.

−20°C

SMILES string

OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(C(=O)NC2=O)C(F)(F)F

InChI

1S/C10H11F3N2O5/c11-10(12,13)4-2-15(9(19)14-8(4)18)7-1-5(17)6(3-16)20-7/h2,5-7,16-17H,1,3H2,(H,14,18,19)/t5-,6+,7+/m0/s1

InChI key

VSQQQLOSPVPRAZ-RRKCRQDMSA-N

Application

三氟胸苷已用作选择性培养基组分,用于筛选淋巴瘤细胞、人淋巴母细胞样细胞TK6和小鼠淋巴瘤细胞L5178Y中的胸苷激酶(TK)突变体。

Biochem/physiol Actions

三氟胸苷(TFT)是一种胸苷类似物,对光敏感。TFT可作为胸苷激酶底物,用于研究该酶的特异性和动力学。磷酸化TFT可掺入DNA,诱导DNA损伤,因而TFT适合用于研究DNA修复机制。TFT也可用于研究胸苷酸合成酶抑制机制和筛选胸苷激酶突变基因。它对胃肠道癌具有抗肿瘤活性,也可用于治疗疱疹病毒性角膜炎。

Packaging

无底玻璃瓶。内含物在插入的融合锥体内。


pictograms

Health hazard

signalword

Warning

Hazard Classifications

Carc. 2 - Muta. 2 - Repr. 2

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


相关内容


Marc Peeters et al.
Future oncology (London, England), 14(16), 1629-1645 (2018-04-28)
Fluoropyrimidines are currently the backbone of treatment for gastrointestinal (GI) cancers but development of resistance to these agents remains a major problem. Trifluridine/tipiracil is an oral chemotherapeutic agent recently approved for third-line treatment of chemorefractory metastatic colorectal cancer. This article
Olaf H Temmink et al.
Molecular cancer therapeutics, 9(4), 1047-1057 (2010-04-08)
Trifluorothymidine (TFT) is part of the novel oral formulation TAS-102, which is currently evaluated in phase II studies. Drug resistance is an important limitation of cancer therapy. The aim of the present study was to induce resistance to TFT in
A A Carmine et al.
Drugs, 23(5), 329-353 (1982-05-01)
Trifluridine (trifluorothymidine) is an antiviral agent for topical use in the eye, and is structurally related to idoxuridine. In vitro studies have shown that it effectively inhibits the replication of herpes simplex virus type 1, which causes primary keratoconjunctivitis and



全球贸易项目编号

货号GTIN
T2255-100MG04061837341939
T2255-1G04061826694541